Timing of onset of gastrointestinal bleeding in the ICU: Protocol for a preplanned observational study
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Timing of onset of gastrointestinal bleeding in the ICU : Protocol for a preplanned observational study. / Granholm, A.; Lange, T.; Anthon, C. T.; Marker, S.; Krag, M.; Meyhoff, T. S.; Wise, M. P.; Borthwick, M.; Bendel, S.; Keus, F.; Guttormsen, A. B.; Schefold, J. C.; Wetterslev, J.; Perner, A.; Møller, M. H.
In: Acta Anaesthesiologica Scandinavica, Vol. 62, No. 8, 09.2018, p. 1165-1170.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Timing of onset of gastrointestinal bleeding in the ICU
T2 - Protocol for a preplanned observational study
AU - Granholm, A.
AU - Lange, T.
AU - Anthon, C. T.
AU - Marker, S.
AU - Krag, M.
AU - Meyhoff, T. S.
AU - Wise, M. P.
AU - Borthwick, M.
AU - Bendel, S.
AU - Keus, F.
AU - Guttormsen, A. B.
AU - Schefold, J. C.
AU - Wetterslev, J.
AU - Perner, A.
AU - Møller, M. H.
PY - 2018/9
Y1 - 2018/9
N2 - BackgroundCritically ill patients are at risk of gastrointestinal bleeding, but clinically important gastrointestinal bleeding is rare. The majority of intensive care unit (ICU) patients receive stress ulcer prophylaxis (SUP), despite uncertainty concerning the balance between benefit and harm. For approximately half of ICU patients with gastrointestinal bleeding, onset is early, ie within the first two days of the ICU stay. The aetiology of gastrointestinal bleeding and consequently the balance between benefit and harm of SUP may differ between patients with early vs late gastrointestinal bleeding.MethodsThis is a protocol and statistical analysis plan for a preplanned exploratory substudy of the Stress Ulcer Prophylaxis in the Intensive Care Unit (SUP‐ICU) randomized clinical trial, comparing intravenous pantoprazole (40 mg once daily) with placebo in 3350 acutely ill adult ICU patients. We will describe baseline characteristics and assess the time to onset of the first clinically important episode of GI bleeding accounting for survival status and allocation to SUP or placebo. In addition, we will describe differences in therapeutic and diagnostic procedures used in patients with clinically important gastrointestinal bleeding according to early vs late bleeding and 90‐day vital status.ConclusionsThe study outlined in this protocol will provide detailed information on patient characteristics and the timing of onset of gastrointestinal bleeding in the patients enrolled in the SUP‐ICU trial. This may provide additional knowledge and incentives for future studies on which patients benefit from SUP.
AB - BackgroundCritically ill patients are at risk of gastrointestinal bleeding, but clinically important gastrointestinal bleeding is rare. The majority of intensive care unit (ICU) patients receive stress ulcer prophylaxis (SUP), despite uncertainty concerning the balance between benefit and harm. For approximately half of ICU patients with gastrointestinal bleeding, onset is early, ie within the first two days of the ICU stay. The aetiology of gastrointestinal bleeding and consequently the balance between benefit and harm of SUP may differ between patients with early vs late gastrointestinal bleeding.MethodsThis is a protocol and statistical analysis plan for a preplanned exploratory substudy of the Stress Ulcer Prophylaxis in the Intensive Care Unit (SUP‐ICU) randomized clinical trial, comparing intravenous pantoprazole (40 mg once daily) with placebo in 3350 acutely ill adult ICU patients. We will describe baseline characteristics and assess the time to onset of the first clinically important episode of GI bleeding accounting for survival status and allocation to SUP or placebo. In addition, we will describe differences in therapeutic and diagnostic procedures used in patients with clinically important gastrointestinal bleeding according to early vs late bleeding and 90‐day vital status.ConclusionsThe study outlined in this protocol will provide detailed information on patient characteristics and the timing of onset of gastrointestinal bleeding in the patients enrolled in the SUP‐ICU trial. This may provide additional knowledge and incentives for future studies on which patients benefit from SUP.
KW - gastrointestinal bleeding
KW - intensive care
KW - intensive care unit
KW - risk factors
KW - stress ulcer prophylaxis
U2 - 10.1111/aas.13144
DO - 10.1111/aas.13144
M3 - Journal article
C2 - 29761482
VL - 62
SP - 1165
EP - 1170
JO - Acta Anaesthesiologica Scandinavica
JF - Acta Anaesthesiologica Scandinavica
SN - 0001-5172
IS - 8
ER -
ID: 210061884